As a non-profit organization for the advancement of life-science research and medicine, it is part of our core mission at Keystone Symposia to support and train the next-wave of research leaders and innovators. The future of science and more specifically biomedicine hinges on our investment in these bright, young minds, by providing them with the skills and inspiration to drive biomedicine in new, transformative directions.
Students and post-doctoral fellows are an integral part of the Keystone Symposia Community.
Not only do future leaders comprise 40% of meeting attendees, but they also bring fresh ideas, insights, and perspectives to launch novel research trajectories and applications. Their voices are an essential part of our meetings and science as a whole. As such we provide scholarship funding to ensure their participation in these global scientific forums.
Scholarships provide the next generation of scientists with unique training and career-development opportunities:
Unique mentorship and networking opportunities with academic, clinical and industry leaders.
New career-round table workshops offer insights into diverse career trajectories.
Poster and short-talk opportunities to showcase student/postdoc research projects side-by-side with field leaders, facilitating expert feedback, guidance and novel perspectives from to point projects in new, fruitful directions.
Small, retreat-like venues that foster a collegial atmosphere where students can form lasting relationships and collaborations with peers and global research leaders alike-- relationships that will shape their research and careers for years to come.
Scholarships provide funding for over 400 students & post-docs annually to attend our conferences, through NIH grants and internal Future of Science Fund sources.
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.